Phil - Headquarter Locations, Products, Competitors ... - CB Insights

• Overview & Products
• Financials
• People
• Alternatives & Competitors

Founded Year

2015

Stage

Debt | Alive

Total Raised

$186.1M

Last Raised

$60M | 6 mos ago

Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+1 points in the past 30 days

About Phil

Phil provides technology solutions in the pharmaceutical sector, focusing on patient access and adherence. The company offers a digital hub and direct-to-patient solutions that assist in the medication access process for patients and healthcare providers. Phil serves pharmaceutical manufacturers, patients, and healthcare providers by offering integrated technology solutions facilitating medication access. It was founded in 2015 and is based in Scottsdale, Arizona.

Headquarters Location

14500 North Northsight Boulevard Suite 307

Scottsdale, Arizona, 85260,

United States

855-977-0975

Loading...

ESPs containing Phil

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGERPrescription delivery & distribution servicesEnterprise Tech / Supply Chain & Procurement

The prescription delivery & distribution services market provides solutions that deliver prescription medications from pharmacies to patients' homes or other designated locations. These services help to ensure timely access to medications, in turn improving medication adherence and enhancing the overall patient experience, particularly for individuals with chronic conditions, mobility limitations,…

Phil named as Challenger among 15 other companies, including Walmart, Amazon, and Instacart.

View all ESPs

Loading...

Research containing Phil

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Phil in 1 CB Insights research brief, most recently on Apr 8, 2024.

Apr 8, 2024

The digital pharmacy tech market mapView all research

Expert Collections containing Phil

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Phil is included in 4 Expert Collections, including E-Commerce.

EE-Commerce

11,526 items

Companies that sell goods online (B2C), or enable the selling of goods online via tech solutions (B2B).

DDigital Health

12,377 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

TTelehealth

3,124 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

HHLTH 2025 Exhibitors

878 items

A look at the HLTH Vegas 2025 exhibitor list we’ve been building so your team can start scanning for relevant companies.

Learn more by requesting a demo

Phil Patents

Phil has filed 45 patents.

The 3 most popular patent topics include:

• graphical projections
• technical drawing
• roadsters

View Patents Chart

Application Date	Grant Date	Title	Related Topics	Status
3/25/2024	12/30/2025	Roof support structure and support straps	Grant

Application Date	3/25/2024
Grant Date	12/30/2025
Title	Roof support structure and support straps
Related Topics
Status	Grant

Learn more by requesting a demo

Latest Phil News

PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in Pharma

Sep 23, 2025

PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in Pharma New platform addresses rising consumer expectations and affordability challenges, using GLP-1 therapies as a proof point Combines affordability-first workflows, telemedicine, fulfillment, and real-time patient support into a single digital front door SAN FRANCISCO--(BUSINESS WIRE)-- PHIL , a leader in patient access solutions for the life sciences industry, today announced the launch of PHIL Direct , its Direct-to-Patient (DTP) 2.0 platform, designed to help pharmaceutical brands meet evolving patient expectations while navigating affordability, compliance, and policy pressures. Direct-to-patient access has evolved from a tactical experiment to a strategic, executive-level priority, as policy shifts, competitive pressures, and consumer demand converge. The consumerization of healthcare is real—patients now demand the same frictionless, digital experiences they get from modern e-commerce. However, cost remains a major barrier to access. The challenge is especially acute in high-demand categories like GLP-1 medications. Despite widespread interest, direct-to-consumer GLP-1 offerings are often priced at $499 per month—out of reach for most. While insured patients might pay as little as $25, studies show 47% of consumers cite cost as the primary barrier, and 36% of former users discontinued treatment due to affordability. Yet the reality of the drug channel, which is characterized by prior authorization hurdles, and complex benefit designs, continues to hinder access, even when coverage exists. PHIL’s DTP 2.0 platform is designed to close this gap by enabling a coverage-first model, with cash-pay as a bridge or fallback—pairing affordability with long-term adherence support. The platform integrates telemedicine, digital hub, prescription fulfillment, real-time patient navigation, and full-spectrum insights into a single digital front door, ensuring a compliant, consumer-grade experience. “Direct-to-Patient has shifted from experiment to imperative for pharma,” said Deepak Thomas, Founder and CEO, PHIL. “GLP-1s have been a case study in both the demand for these therapies and the barriers that prevent patients from staying on them. Backed by over five years of success enabling DTP for leading brands, we’re proud to launch PHIL Direct—our DTP 2.0 platform that empowers patients to start and stay on therapy affordably, while giving pharma the guardrails required for scalable, compliant growth.” Sari Kaganoff, Former Chief Commercial Officer, Rock Health, added, “Pharma has experimented with DTP for years now, but it’s been in small pockets. Now with policy shifts demanding DTP options, leading pharma companies going big, and changing consumer expectations, the industry is forced to take action. PHIL’s DTP 2.0 solution provides a way for companies to quickly launch a DTP offering that maximizes access and affordability.” Michelle Keefe, Former Chief Executive Officer, Syneos Health, shared her perspective, "Pharma brands today face a critical challenge – the traditional path to access is filled with high barriers and friction points for patients. Direct-to-patient programs are shifting the paradigm, creating a seamless digital experience for patients that empowers brands to build a more resilient and profitable commercial strategy." About PHIL PHIL is a patient access and commercialization platform, offering pharmaceutical brands a modern alternative to traditional access, affordability and distribution options. Through its digital stakeholder experiences, patient access services, market access solutions and distribution models, pharma brands are able to deliver affordable and timely therapy access to patients. For more information on PHIL, visit https://phil.us/ . Contacts

Sep 22, 2025PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in PharmaSep 22, 2025PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in PharmaJul 28, 2025Redefining commercial success in specialty lite with alternative channelsJul 15, 2025Phil: $60 Million Growth Debt Raised For Advancing AI-Based Pharma CommercializationLearn more by requesting a demo

Phil Frequently Asked Questions (FAQ)

• When was Phil founded?

  Phil was founded in 2015.

• Where is Phil's headquarters?

  Phil's headquarters is located at 14500 North Northsight Boulevard, Scottsdale.

• What is Phil's latest funding round?

  Phil's latest funding round is Debt.

• How much did Phil raise?

  Phil raised a total of $186.1M.

• Who are the investors of Phil?

  Investors of Phil include K2 HealthVentures, Warburg Pincus, Uncork Capital, Crosslink Capital, Tarsadia Investments and 17 more.

• Who are Phil's competitors?

  Competitors of Phil include Alto Pharmacy, Blink Health, Truepill, Medly, Arrive Health and 7 more.

Loading...

Compare Phil to Competitors

Capsule

Capsule is a pharmacy technology company that offers prescription delivery services. The company provides same-day prescription delivery and facilitates communication with pharmacists via text or chat. Capsule primarily serves individuals who require medication management. It was founded in 2015 and is based in New York, New York.

Blink Health

Blink Health operates in the healthcare sector, focusing on providing a digital concierge service for patients prescribed branded medications. The company offers a centralized platform that ensures patients have access to low prices and home delivery, addressing issues faced at pharmacies. BlinkRx primarily serves the pharmaceutical and healthcare services industry. It was founded in 2014 and is based in New York, New York.

Nimble

Nimble provides pharmacy and prescription management solutions within the healthcare sector. The company offers services that focus on digital ordering and operational processes, as well as marketing strategies aimed at patient retention and adherence to prescriptions. Nimble serves pharmacies, patients, and manufacturers in the healthcare industry. Nimble was formerly known as Nimble Pharmacy. It was founded in 2015 and is based in Redwood City, California.

Arrive Health

Arrive Health serves as a healthcare technology company that focuses on improving care decisions for patients and providers. The company offers solutions that provide accurate clinical, cost, and coverage data within electronic health record (EHR) systems and other healthcare workflows to support informed decision-making. Arrive Health primarily serves sectors such as health systems, providers, health plans, pharmacy benefit managers (PBMs), and technology vendors in the healthcare industry. Arrive Health was formerly known as RxRevu. It was founded in 2013 and is based in Denver, Colorado.

ScriptDrop

ScriptDrop focuses on medication access and prescription delivery within the healthcare sector. The company offers a platform for pharmacies, providers, and patients to facilitate medication delivery. ScriptDrop primarily serves pharmacies and healthcare providers. It was founded in 2016 and is based in Columbus, Ohio.

PPopulus Health Technologies

Populus Health Technologies focuses on virtual care patient acquisition within the healthcare and pharmaceutical sectors. The company provides a platform that integrates brand and clinical messaging into virtual care consultations. Populus Health Technologies serves the healthcare industry, concentrating on virtual care media and provider engagement. Populus Health Technologies was formerly known as Populus Media. It was founded in 2019 and is based in Princeton, New Jersey.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.

I ACCEPTI DO NOT ACCEPT